Molbio Diagnostics Limited

Sriram NatarajanExecutive Director and Chief

Yes. Thank you very much. I would like to start first of all by thanking all the investors for their overwhelming response to our IPO. It just further strengthens our belief and our mission to carry forward high-technology solutions for the underserved population. So, Molbio was set up fundamentally with a mission to design and develop technologies that would ensure access to high-quality diagnostics at the lowest levels of the healthcare chain. And one such technology which was waiting for a long time was the molecular diagnostics area, and here is what where we worked to develop a technology called Truenat, which is a multidisease molecular testing platform, which is battery-operated and portable, and can be taken to the lowest levels of the chain.

The journey started quite early, so I started my entrepreneurial career from 1990 when I first set up the company, Tulip Diagnostics. And this company, over a period of 27 years, grew to be the largest diagnostic manufacturing company in India and the largest exporter of diagnostics. And while in this company, I knew that one area we had not explored was molecular diagnostics, and the future was there because molecular diagnostics is the only solution which is capable of diagnosing very, very early on infectious diseases, very, very accurately. So, I was thinking about this, and that's when I met my partner and co-founder, Chandrasekhar Nair, who had started Bigtec Laboratories, a completely private R&D operation, and they were also thinking on the same lines. So, when we met in 2009, he was making a presentation about the prototype they had developed for a battery-operated, portable molecular solution. And so, we got together and discussed how we can take it further, commercialize it. Took us another about seven, eight years before we could finally have the current version of Truenat as a multi-disease molecular testing platform, which now works even in a primary level of introduction.